Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 548t (MIR548T)
- Target
- MIR548T
- Molecular classification
- microRNA (miRNA)
01
Overview
MicroRNA 548t (MIR548T) is a primate-specific, poorly conserved microRNA belonging to a larger gene family distributed across human chromosomes. MIR548T is transcribed as a primary transcript and processed into a mature miRNA that incorporates into the RNA-induced silencing complex (RISC), guiding gene silencing through sequence-specific binding and regulatory effects on mRNA stability and translation. Broad enrichment analysis shows the family is involved in numerous signaling pathways, regulation of cytoskeleton, adhesion, cell cycle, apoptosis, and cell differentiation, and is associated with multiple cancer types and other complex diseases. MIR548T is referenced primarily in genomic and transcriptomic research and does not have a specific clinical therapeutic, diagnostic, or biomarker role currently documented.
- Other names
- hsa-mir-548tMIR548TmicroRNA 548t
02
Mechanism of action
Not applicable specifically; general mechanism for miRNA targeting includes RNA interference, translation inhibition, and mRNA destabilization
03
Biological functions
Post-transcriptional gene regulationInhibition or destabilization of target mRNA translationRegulation of cell signaling pathways (MAPK, Wnt, p53, etc.)Modulation of cell cycle, apoptosis, cytoskeleton, and cell adhesion dynamics
04
Disease associations
Cancer (colorectal cancer, glioma, nonsmall cell lung cancer, breast cancer)Neurodegenerative disease (Alzheimer's disease)Other: Potentially involved in diverse cellular processes due to broad target spectrum
05
Safety considerations
Not individually documented for MIR548TGeneral concerns for miRNA-targeting therapeutics include off-target effectsImmune activationUnpredictable impact on gene networks
06
Biomarkers
Members of the miR-548 family (not MIR548T specifically) have been implicated as biomarkers in breast cancer and other cancers
Beyond the preview
Go deeper on MicroRNA 548t (MIR548T).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MicroRNA 548t (MIR548T).